Delta Biopharma Private Limited — Empagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Empagliflozin · $234.4K export value · DGFT Verified
Delta Biopharma Private Limited is the #7 Indian exporter of Empagliflozin with $234.4K in export value and 15 verified shipments. Delta Biopharma Private Limited holds a 3.5% market share in Empagliflozin exports across 2 countries. The company exports 5 pharmaceutical products worth $1.1M across 4 therapeutic categories.
Delta Biopharma Private Limited — Empagliflozin Export Profile: Buyers & Destinations

Where Does Delta Biopharma Private Limited Export Empagliflozin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $176.1K | 11 | 72.3% |
| THAILAND | $67.3K | 6 | 27.7% |
Delta Biopharma Private Limited exports Empagliflozin to 2 countries. The largest destination is MYANMAR accounting for 72.3% of Delta Biopharma Private Limited's Empagliflozin shipments. These destinations reflect Delta Biopharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Empagliflozin from Delta Biopharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PINNACLE HOUSE CO., LTD | THAILAND | $170.4K | 10 |
| PINNACLE HOUSE CO LTD | MYANMAR | $41.3K | 2 |
| PINNACLE HOUSE CO, LTD | MYANMAR | $13.4K | 1 |
| PINNACLE HOUSE CO. LTD | MYANMAR | $13.2K | 1 |
| PINNACLE HOUSE CO LIMITED | MYANMAR | $5.1K | 3 |
Delta Biopharma Private Limited supplies Empagliflozin to 5 buyers globally. The largest buyer is PINNACLE HOUSE CO., LTD (THAILAND), followed by PINNACLE HOUSE CO LTD (MYANMAR) and PINNACLE HOUSE CO, LTD (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Empagliflozin Export Value and How Much Does Delta Biopharma Private Limited Contribute?
India exported $4.8M worth of Empagliflozin through 3,528 shipments from 170 suppliers to 75 countries, serving 236 buyers globally. Delta Biopharma Private Limited contributes $234.4K to this total, accounting for 3.5% of India's Empagliflozin exports. Delta Biopharma Private Limited ships Empagliflozin to 2 countries through 5 buyers.
What Is the Average Shipment Value for Delta Biopharma Private Limited's Empagliflozin Exports?
Delta Biopharma Private Limited's average Empagliflozin shipment value is $15.6K per consignment, based on 15 shipments totaling $234.4K. The largest destination is MYANMAR (72.3% of Delta Biopharma Private Limited's Empagliflozin exports).
How Does Delta Biopharma Private Limited Compare to Other Indian Empagliflozin Exporters?
Delta Biopharma Private Limited ranks #7 among 170 Indian Empagliflozin exporters with a 3.5% market share. The top 3 exporters are LAWRENCE WALTER ($848.8K), BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED ($681.8K), HEXA HEALTH CARE PRIVATE LIMITED ($675.4K). Delta Biopharma Private Limited processed 15 shipments to 2 destination countries.
What Empagliflozin Formulations Does Delta Biopharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| "Emflozin 25mg (Empagliflozin Tablet 25mg) MYR Regn No: 2610EA00358 BATCH No: DF0044 Each pack contains=30Tablets MFG D | $50.0K | 1 |
| EMFLOZIN 25MG (EMPAGLIFLOZIN TABLET 25 MG) MYR REGN NO: 2610EA00358 MFG DT: 12/2023; EXP DT: 11/2026 BATCH NO: CL0017 | $40.9K | 3 |
| "Emflozin 10mg (Empagliflozin Tablet 10mg) PACK SIZE: 3X10'S MYR Regn No: 2610EA00359 BATCH No.DF0045 MFG Dt: 06/2024; | $39.1K | 1 |
| "EMFLOZIN 25[EMPAGLIFLOZIN TABLETS 25 MG | $27.5K | 1 |
| EMFLOZIN 10MG (EMPAGLIFLOZIN TABLET 10 MG) MYR REGN NO: 2610EA00359 MFG DT: 03/2024; EXP DT: 02/2027 BATCH NO: DC0009 | $26.4K | 3 |
| EMFLOZIN 25 EMPAGLIFLOZIN TABLETS 25 MG PACK SIZE 3X10S MYANMAR REG NO 2610EA00358 BATCH NO CG0016 | $13.8K | 1 |
| EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG | $13.4K | 1 |
| EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG ) MYANMAR REG NO. 2610EA00359 PACK SIZE. 3 X 10 S MFG DT. JAN 2025, EXP DT. DEC | $13.2K | 1 |
| EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG) Myanmar Reg No: 2610EA00359 Pack Size: 3 X 10'S MFG Dt: JAN 2025; EXP Dt: DEC | $13.2K | 1 |
| EMFLOZIN 10 (EMPAGLIFLOZIN TABLETS 10 MG) MYANMAR REG NO 2610EA00359 PACK SIZE 3 X 10S MFG DT SEP 2023 EXP DT ANOS | $5.1K | 3 |
Delta Biopharma Private Limited exports 11 distinct Empagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is "Emflozin 25mg (Empagliflozin Tablet 25mg) MYR Regn No: 2610 with 1 shipments worth $50.0K.
How Does Delta Biopharma Private Limited Compare to Nearest Empagliflozin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | SCOTT EDIL PHARMACIA LIMITED | $260.7K | 12 | 4 | $21.7K |
| 6 | PLEASANT EXPORTS | $254.7K | 128 | 2 | $2.0K |
| 7 | DELTA BIOPHARMA PRIVATE LIMITED ★ | $234.4K | 15 | 2 | $15.6K |
| 8 | LOTUS INTERNATIONAL | $227.9K | 11 | 2 | $20.7K |
| 9 | KWALITY PHARMACEUTICALS LIMITED | $205.3K | 24 | 5 | $8.6K |
Delta Biopharma Private Limited ranks #7 among 170 Indian Empagliflozin exporters. Average shipment value of $15.6K compared to the market average of $28.2K. The closest competitors by value are SCOTT EDIL PHARMACIA LIMITED and PLEASANT EXPORTS.
Which Indian Ports Ship Empagliflozin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,041 | 29.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 543 | 15.4% |
| DELHI AIR CARGO ACC (INDEL4) | 484 | 13.7% |
| DELHI AIR | 394 | 11.2% |
| Bombay Air | 145 | 4.1% |
| Bombay Air Cargo | 115 | 3.3% |
| Delhi Air Cargo | 94 | 2.7% |
| CHENNAI AIR | 69 | 2.0% |
About Delta Biopharma Private Limited
Delta Biopharma Private Limited exports 5 products worth $1.1M. Beyond Empagliflozin, top products include Efavirenz, Sofosbuvir, Emtricitabine, Linagliptin. View the complete Delta Biopharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Empagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Empagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Delta Biopharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching Delta Biopharma Private Limited exporting Empagliflozin, covering 11 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 75+ countries, 236+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Empagliflozin Export Data from Delta Biopharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Delta Biopharma Private Limited's Empagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Delta Biopharma Private Limited
Full Company Profile →
5 products · $1.1M total trade · 4 categories
Empagliflozin Stats
Company Overview
Top Products by Delta Biopharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Delta Biopharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Empagliflozin. For current shipment-level data, contact TransData Nexus.